Mutation screening in the FBN1 gene responsible for Marfan syndrome and related disorder in Chinese families

被引:6
作者
Gong, Bo [1 ,2 ,3 ,4 ]
Yang, Lan [3 ,5 ,6 ]
Wang, Qingwei [1 ,2 ,3 ,4 ]
Ye, Zimeng [7 ]
Guo, Xiaoxin [1 ,2 ,3 ]
Yang, Chen [1 ,2 ,3 ]
Hao, Fang [1 ,2 ,3 ]
Shi, Yi [1 ,2 ,3 ]
Huang, Yi [1 ,2 ,3 ]
Qu, Chao [3 ,4 ,5 ]
Yang, Zhenglin [1 ,2 ,3 ,4 ]
机构
[1] Sichuan Acad Med Sci, Sichuan Prov Key Lab Dis Gene Study, Chengdu, Sichuan, Peoples R China
[2] Sichuan Acad Med Sci, Dept Lab Med, Chengdu, Sichuan, Peoples R China
[3] Univ Elect Sci & Technol China, Sichuan Prov Peoples Hosp, Sch Med, Chengdu, Sichuan, Peoples R China
[4] Sichuan Translat Med Hosp, Chinese Acad Sci, Inst Chengdu Biol, Chengdu, Sichuan, Peoples R China
[5] Sichuan Acad Med Sci, Dept Ophthalmol, Chengdu, Sichuan, Peoples R China
[6] Southwest Med Univ, Sch Clin Med, Luzhou, Sichuan, Peoples R China
[7] Univ Melbourne, Sch Med Dent & Hlth Sci, Melbourne, Vic, Australia
来源
MOLECULAR GENETICS & GENOMIC MEDICINE | 2019年 / 7卷 / 04期
关键词
fibrillin-1 (FBN1); heterozygous mutation; Marfan syndrome (MFS); targeted next-generation sequencing (NGS); FIBRILLIN-1; IDENTIFICATION; PATHOGENESIS; GENOTYPE;
D O I
10.1002/mgg3.594
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background Previous studies showed that the fibrillin-1 gene (FBN1) is responsible for Marfan sydrome (MFS) pathogenesis. This study is conducted to screen for mutations in the FBN1 gene in Chinese families with MFS. Methods Eight families with MFS and related disorder were recruited in this study. All available family members underwent complete physical, ophthalmic, and cardiovascular examination. Mutation screening was performed using targeted next-generation sequencing. Candidate variants were amplified by polymerase chain reaction and verified by direct Sanger sequencing. Results Four novel heterozygous mutations in FBN1, including c.2861G>T (p.R954L), c.4087G>A (p.D1363N), c.4987T>G (p.C1663G), and c.5032T>G (p.Y1678D), as well as four known mutations, c.3617G>A (p.G1206D), c.4460A>G (p.D1487G), c.4588C>T (p.R1530C), and c.718C>T (p.R240C) were identified. Affected patients from each family were found to carry one of the mutations, whereas the unaffected members and 1,086 normal controls were not. Each mutation was found to be cosegregated with MFS phenotype and related disorder in each family. Multiple sequence alignment of the human fibrillin-1 protein showed that these mutations occurred in a highly conserved region among different species. Conclusions Eight FBN1 mutations were identified in Chinese families with MFS and related disorder. These data expands FBN1 mutation spectrum and further emphasizes the role of FBN1 in the pathogenesis of MFS.
引用
收藏
页数:10
相关论文
共 23 条
[1]   Marfan Database (third edition):: new mutations and new routines for the software [J].
Collod-Béroud, G ;
Béroud, C ;
Ades, L ;
Black, C ;
Boxer, M ;
Brocks, DJH ;
Holman, KJ ;
de Paepe, A ;
Francke, U ;
Grau, U ;
Hayward, C ;
Klein, HG ;
Liu, WG ;
Nuytinck, L ;
Peltonen, L ;
Perez, ABA ;
Rantamäki, T ;
Junien, C ;
Boileau, C .
NUCLEIC ACIDS RESEARCH, 1998, 26 (01) :229-233
[2]   THE QUESTION OF HETEROGENEITY IN MARFAN-SYNDROME [J].
DIETZ, H ;
FRANCKE, U ;
FURTHMAYR, H ;
FRANCOMANO, C ;
DEPAEPE, A ;
DEVEREUX, R ;
RAMIREZ, F ;
PYERITZ, R .
NATURE GENETICS, 1995, 9 (03) :228-229
[3]  
Dietz Harry C., 1992, Human Mutation, V1, P366, DOI 10.1002/humu.1380010504
[4]   4 NOVEL FBN1 MUTATIONS - SIGNIFICANCE FOR MUTANT TRANSCRIPT LEVEL AND EGF-LIKE DOMAIN CALCIUM-BINDING IN THE PATHOGENESIS OF MARFAN-SYNDROME [J].
DIETZ, HC ;
MCINTOSH, I ;
SAKAI, LY ;
CORSON, GM ;
CHALBERG, SC ;
PYERITZ, RE ;
FRANCOMANO, CA .
GENOMICS, 1993, 17 (02) :468-475
[5]   MARFAN-SYNDROME CAUSED BY A RECURRENT DENOVO MISSENSE MUTATION IN THE FIBRILLIN GENE [J].
DIETZ, HC ;
CUTTING, GR ;
PYERITZ, RE ;
MASLEN, CL ;
SAKAI, LY ;
CORSON, GM ;
PUFFENBERGER, EG ;
HAMOSH, A ;
NANTHAKUMAR, EJ ;
CURRISTIN, SM ;
STETTEN, G ;
MEYERS, DA ;
FRANCOMANO, CA .
NATURE, 1991, 352 (6333) :337-339
[6]  
Dong JM, 2012, MOL VIS, V18, P81
[7]   Effect of mutation type and location on clinical outcome in 1,013 probands with Marfan syndrome or related phenotypes and FBN1 mutations:: An international study [J].
Faivre, L. ;
Collod-Beroud, G. ;
Loeys, B. L. ;
Child, A. ;
Binquet, C. ;
Gautier, E. ;
Callewaert, B. ;
Arbustini, E. ;
Mayer, K. ;
Arslan-Kirchner, M. ;
Kiotsekoglou, A. ;
Comeglio, P. ;
Marziliano, N. ;
Dietz, H. C. ;
Halliday, D. ;
Beroud, C. ;
Bonithon-Kopp, C. ;
Claustres, M. ;
Muti, C. ;
Plauchu, H. ;
Robinson, P. N. ;
Ades, L. C. ;
Biggin, A. ;
Benetts, B. ;
Brett, M. ;
Holman, K. J. ;
De Backer, J. ;
Coucke, P. ;
Francke, U. ;
De Paepe, A. ;
Jondeau, G. ;
Boileau, C. .
AMERICAN JOURNAL OF HUMAN GENETICS, 2007, 81 (03) :454-466
[8]   Prevalence, incidence, and age at diagnosis in Marfan Syndrome [J].
Groth, Kristian A. ;
Hove, Hanne ;
Kyhl, Kasper ;
Folkestad, Lars ;
Gaustadnes, Mette ;
Vejlstrup, Niels ;
Stochholm, Kirstine ;
Ostergaard, John R. ;
Andersen, Niels H. ;
Gravholt, Claus H. .
ORPHANET JOURNAL OF RARE DISEASES, 2015, 10
[9]  
Jin CF, 2007, MOL VIS, V13, P1280
[10]  
Judge DP, 2005, LANCET, V366, P1965, DOI 10.1016/S0140-6736(05)67789-6